Related Experiment Video
Updated: Aug 9, 2026

Generation of Monocyte-Derived Dendritic Cells with Differing Sialylated Phenotypes
Published on: October 20, 2023
Sialic acid: a novel marker of cardiovascular disease?
Karina P Gopaul1, Martin A Crook
1Guy's, King's, and St. Thomas' Hospitals School of Medicine, King's College London, London, UK.
Insights
Serum total sialic acid (TSA) may indicate cardiovascular disease (CVD) risk. While linked to mortality, its role in atherosclerosis severity and inflammation requires further investigation, with ethnic variations noted.
Area of Science:
- Biochemistry
- Epidemiology
- Cardiovascular Medicine
Background:
- Cardiovascular disease (CVD) poses a significant global health burden.
- Emerging research suggests sialic acid (SA) may be a potential risk factor for CVD.
- Existing studies show mixed results regarding the association between serum TSA and atherosclerosis severity.
Purpose of the Study:
- To review current methods for determining serum TSA.
- To evaluate evidence supporting serum TSA as a CVD risk factor.
- To examine potential mechanisms and the role of serum TSA in atherosclerotic disease.
Main Methods:
- Literature review of epidemiological and clinical studies.
- Analysis of data on serum TSA determination methods.
- Examination of proposed biological mechanisms.
Main Results:
- Large-scale surveys indicate a positive association between serum TSA and mortality from coronary artery disease (CAD) and stroke.
- Clinical studies suggest serum TSA acts as a marker of sustained inflammation in CVD, not a direct cause.
- Evidence for serum TSA as a direct risk factor for atherosclerosis severity is conflicting, with noted ethnic variations.
Conclusions:
- Serum TSA may serve as a marker for inflammatory responses in CVD.
- Further research is needed to clarify the causal role of serum TSA in CVD and atherosclerosis.
- Understanding ethnic variations in TSA is crucial for accurate risk assessment.
Abstract:
The global burden posed by cardiovascular disease (CVD), due to a rising incidence of known risk factors, underlines an urgent need to identify other potential risk factors. Sialic acid (SA), an abundant terminal monosaccharide of glycoconjugates, is a possible risk factor for CVD. Although large-scale epidemiological surveys have shown that serum total sialic acid (TSA) is positively associated with mortality from coronary artery disease (CAD) and stroke, studies investigating the correlation between serum TSA and the severity of atherosclerosis are conflicting. Clinical and epidemiological studies indicate that serum TSA is a marker of a sustained inflammatory response in CVD, rather than causal in nature. Data also indicates ethnic variation in baseline TSA. This article reviews current methods for determining serum TSA and evidence supporting serum TSA as a risk factor for CVD. Potential mechanisms for this role are examined. The use of serum TSA as a marker of atherosclerotic disease is evaluated.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease III: Clinical Manifestations
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies

